Related references
Note: Only part of the references are listed.The cytokine storm and COVID-19
Biying Hu et al.
JOURNAL OF MEDICAL VIROLOGY (2021)
Bi-paratopic and multivalent VH domains block ACE2 binding and neutralize SARS-CoV-2
Colton J. Bracken et al.
NATURE CHEMICAL BIOLOGY (2021)
Rational development of a human antibody cocktail that deploys multiple functions to confer Pan-SARS-CoVs protection
Hangping Yao et al.
CELL RESEARCH (2021)
Structure-based development of human antibody cocktails against SARS-CoV-2
Nan Wang et al.
CELL RESEARCH (2021)
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
Roujian Lu et al.
LANCET (2020)
Convalescent plasma as a potential therapy for COVID-19
Long Chen et al.
LANCET INFECTIOUS DISEASES (2020)
A new coronavirus associated with human respiratory disease in China
Fan Wu et al.
NATURE (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody
Xiaolong Tian et al.
EMERGING MICROBES & INFECTIONS (2020)
Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma
Chenguang Shen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Deployment of convalescent plasma for the prevention and treatment of COVID-19
Evan M. Bloch et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2
Yan Wu et al.
SCIENCE (2020)
Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period
Stephen M. Kissler et al.
SCIENCE (2020)
Highlight of Immune Pathogenic Response and Hematopathologic Effect in SARS-CoV, MERS-CoV, and SARS-Cov-2 Infection
Yanwen Liang et al.
FRONTIERS IN IMMUNOLOGY (2020)
Progress and Prospects on Vaccine Development against SARS-CoV-2
Jinyong Zhang et al.
VACCINES (2020)
Making Sense of Mutation: What D614G Means for the COVID-19 Pandemic Remains Unclear
Nathan D. Grubaugh et al.
CELL (2020)
Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients' B Cells
Yunlong Cao et al.
CELL (2020)
Mutations Strengthened SARS-CoV-2 Infectivity
Jiahui Chen et al.
JOURNAL OF MOLECULAR BIOLOGY (2020)
A Therapeutic Non-self-reactive SARS-CoV-2 Antibody Protects from Lung Pathology in a COVID-19 Hamster Model
Jakob Kreye et al.
CELL (2020)
Structurally Resolved SARS-CoV-2 Antibody Shows High Efficacy in Severely Infected Hamsters and Provides a Potent Cocktail Pairing Strategy
Shuo Du et al.
CELL (2020)
Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology
Luca Piccoli et al.
CELL (2020)
Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike
Lihong Liu et al.
NATURE (2020)
Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections
Quan-Xin Long et al.
NATURE MEDICINE (2020)
A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2
Xiangyang Chi et al.
SCIENCE (2020)
Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody
Zhe Lv et al.
SCIENCE (2020)
Structural basis of a shared antibody response to SARS-CoV-2
Meng Yuan et al.
SCIENCE (2020)
Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms
M. Alejandra Tortorici et al.
SCIENCE (2020)
The ORF6, ORF8 and nucleocapsid proteins of SARS-CoV-2 inhibit type I interferon signaling pathway
Jin-Yan Li et al.
VIRUS RESEARCH (2020)
Host Immune Response Driving SARS-CoV-2 Evolution
Rui Wang et al.
VIRUSES-BASEL (2020)
Cross-Neutralization of a SARS-CoV-2 Antibody to a Functionally Conserved Site Is Mediated by Avidity
Hejun Liu et al.
IMMUNITY (2020)
De novo design of potent and resilient hACE2 decoys to neutralize SARS-CoV-2
Thomas W. Linsky et al.
SCIENCE (2020)
Selection, biophysical and structural analysis of synthetic nanobodies that effectively neutralize SARS-CoV-2
Tania F. Custodio et al.
NATURE COMMUNICATIONS (2020)
Immune response in COVID-19: addressing a pharmacological challenge by targeting pathways triggered by SARS-CoV-2
Michele Catanzaro et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
A topology-based network tree for the prediction of protein-protein binding affinity changes following mutation
Menglun Wang et al.
NATURE MACHINE INTELLIGENCE (2020)
COVID-19, immune system response, hyperinflammation and repurposing antirheumatic drugs
Abdurrahman Tufan et al.
TURKISH JOURNAL OF MEDICAL SCIENCES (2020)
Structural and molecular basis of mismatch correction and ribavirin excision from coronavirus RNA
Francois Ferron et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
GISAID: Global initiative on sharing all influenza data - from vision to reality
Yuelong Shu et al.
EUROSURVEILLANCE (2017)
Mechanisms of viral mutation
Rafael Sanjuan et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2016)
RaptorX-Property: a web server for protein structure property prediction
Sheng Wang et al.
NUCLEIC ACIDS RESEARCH (2016)
Structural and physico-chemical effects of disease and non-disease nsSNPs on proteins
Tugba G. Kucukkal et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2015)
Persistent homology analysis of protein structure, flexibility, and folding
Kelin Xia et al.
INTERNATIONAL JOURNAL FOR NUMERICAL METHODS IN BIOMEDICAL ENGINEERING (2014)
Insights into RNA synthesis, capping, and proofreading mechanisms of SARS-coronavirus
Marion Sevajol et al.
VIRUS RESEARCH (2014)
Structural analysis of B-cell epitopes in antibody:protein complexes
Jens Vindahl Kringelum et al.
MOLECULAR IMMUNOLOGY (2013)
Bioinformatic prediction of epitopes in the Emy162 antigen of Echinococcus multilocularis
Yanhua Li et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2013)
Pathogen Recognition by the Innate Immune System
Himanshu Kumar et al.
INTERNATIONAL REVIEWS OF IMMUNOLOGY (2011)
CD-HIT Suite: a web server for clustering and comparing biological sequences
Ying Huang et al.
BIOINFORMATICS (2010)
Pattern Recognition Receptors and Inflammation
Osamu Takeuchi et al.
CELL (2010)
Overview of the immune response
David D. Chaplin
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
Pathogen recognition in the innate immune response
Himanshu Kumar et al.
BIOCHEMICAL JOURNAL (2009)
TOPOLOGY AND DATA
Gunnar Carlsson
BULLETIN OF THE AMERICAN MATHEMATICAL SOCIETY (2009)
Llama Antibody Fragments with Cross-Subtype Human Immunodeficiency Virus Type 1 (HIV-1)-Neutralizing Properties and High Affinity for HIV-1 gp120
Anna Forsman et al.
JOURNAL OF VIROLOGY (2008)
Antibody structure, instability, and formulation
Wei Wang et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2007)
Loss of protein structure stability as a major causative factor in monogenic disease
P Yue et al.
JOURNAL OF MOLECULAR BIOLOGY (2005)
The MHC class I antigen presentation pathway: strategies for viral immune evasion
EW Hewitt
IMMUNOLOGY (2003)
Genetic control of MHC class II expression
JPY Ting et al.
CELL (2002)
Share Paper
